Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.58 |
| ▸ | HTR6 | P50406 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 3/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | DRD2 | P14416 | 2/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31291099 | 1.00 | HTR7 (0.58) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL2290990 | 0.99 | HTR7 (0.60) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL4473899 | 0.88 | PDE1A (0.54) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL458792 | 0.85 | HTR7 (0.63) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL29375465 | 0.85 | HTR7 (0.63) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL2626922 | 0.85 | HTR7 (0.63) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL4401766 | 0.84 | HTR7 (0.62) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL12804036 | 0.84 | HTR7 (0.62) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL2290149 | 0.84 | HTR7 (0.65) | HTR7HTR6TSHRRXFP1L3MBTL1 | |
| SCHEMBL4399057 | 0.84 | TSHR (0.72) | HTR7HTR6TSHRRXFP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105012306-A | SAA derivative compounds in hypoxic state are capable of reducing eNOS and inhibiting oxidative stress induced diseases | JIANZHI BIOLOG TECHNOLOGY CO LTD | 2015-11-04 | — | — | CN | claimed |
| WO-2015161510-A1 | SAA DERIVATIVE COMPOUND RESTORES ENOS AND INHIBITS OXIDATIVE STRESS-INDUCED DISEASES IN HYPOXIA | JANSFAT BIOTECHNOLOGY CO., LTD. (CN) | 2015-10-29 | — | — | WO | claimed |
| US-20150306107-A1 | SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia | JANSFAT BIOTECHNOLOGY CO., LTD. (TW) | 2015-10-29 | — | — | US | claimed |
| US-20150174157-A1 | INHALED NO DONOR PIPERAZINYL DERIVATIVE PREVENTING ALLERGIC PULMONARY VASCULAR AND BRONCHIAL INFLAMMATION BY REDUCING VEGF AND RESTORING eNOS IN HYPOXIC PULMONARY ARTERY | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2015-06-25 | — | — | US | claimed |
| US-20130202549-A1 | USE OF DPAS AND CO-POLYMERS FOR HYPERLIPIDEMIA AND ATHEROSCLEROSIS ALONG WITH REDUCING FEEDING RATE AND ADIPOSE TISSUE WEIGHT OF OBESITY ANIMAL | CHEN ING-JUN (TW) | 2013-08-08 | — | — | US | claimed |
| US-20130095059-A1 | INHALED NO DONOR KMUPS DERIVATIVE PREVENTING ALLERGIC PULMONARY VASCULAR AND BRONCHIAL INFLAMMATION VIA SUPPRESSED CYTOKINES, INOS AND INFLAMMATORY CELL COUNTS IN ASTHMA MODEL | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-04-18 | — | — | US | claimed |
| US-20190008870-A1 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | JANSFAT BIOTECHNOLOGY CO LTD (TW) | 2019-01-10 | — | — | US | disclosed |
| EP-3241552-A1 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | Jansfat Biotechnology Co., Ltd. (TW) | 2017-11-08 | — | — | EP | disclosed |
| US-20170312286-A1 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | JANSFAT BIOTECHNOLOGY CO., LTD. (TW) | 2017-11-02 | — | — | US | disclosed |
| EP-2992885-A2 | METHOD FOR INHIBITING A LIVER DISEASE | Jansfat Biotechnology Co., Ltd. (TW) | 2016-03-09 | — | — | EP | disclosed |
| CN-105380949-A | Composition for treating high fat food induced liver lipopexia | JANSFAT BIOTECHNOLOGY CO LTD | 2016-03-09 | — | — | CN | disclosed |
| US-20150359901-A1 | PIPERAZINYL DERIVATIVE REDUCES HIGH-FAT DIET-INDUCED ACCUMULATION OF FAT IN THE LIVERS, THERAPEUTICALLY | JANSFAT BIOTECHNOLOGY CO., LTD. (TW) | 2015-12-17 | — | — | US | disclosed |
| US-20150359798-A1 | PIPERAZINYL DERIVATIVE REDUCES HIGH-FAT DIET-INDUCED ACCUMULATION OF FAT IN THE LIVERS, THERAPEUTICALLY | JANSFAT BIOTECHNOLOGY CO., LTD. (TW) | 2015-12-17 | — | — | US | disclosed |
| US-20130202549-A1 | USE OF DPAS AND CO-POLYMERS FOR HYPERLIPIDEMIA AND ATHEROSCLEROSIS ALONG WITH REDUCING FEEDING RATE AND ADIPOSE TISSUE WEIGHT OF OBESITY ANIMAL | CHEN ING-JUN (TW) | 2013-08-08 | — | — | US | disclosed |
| US-20130095059-A1 | INHALED NO DONOR KMUPS DERIVATIVE PREVENTING ALLERGIC PULMONARY VASCULAR AND BRONCHIAL INFLAMMATION VIA SUPPRESSED CYTOKINES, INOS AND INFLAMMATORY CELL COUNTS IN ASTHMA MODEL | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-04-18 | — | — | US | disclosed |
| CN-102973566-A | DPAs and high molecular polymer for hyperlipemia and reducing food intake amount and adipose tissue weight of obese animals | CHEN YINGJUN | 2013-03-20 | — | — | CN | disclosed |
| US-20110201618-A1 | KMUPS INHIBITING PROLIFERATION AND OBLITERATION OF PULMONARY ARTERY | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2011-08-18 | — | — | US | disclosed |
| US-7550468-B2 | Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase | CHEN ING-JUN | 2009-06-23 | — | — | US | disclosed |
| US-20080064705-A1 | Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation | KAOHSIUNG MEDICAL UNIVERSITY | 2008-03-13 | — | — | US | disclosed |
| US-20050209242-A1 | Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase | CHEN ING-JUN | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095059-A1 | INHALED NO DONOR KMUPS DERIVATIVE PREVENTING ALLERGIC PULMONARY VASCULAR AND BRONCHIAL INFLAMMATION VIA SUPPRESSED CYTOKINES, INOS AND INFLAMMATORY CELL COUNTS IN ASTHMA MODEL | NOS1, NOS3, NOS2 | HTR7 1664/4885HTR6 1719/4885TSHR 2884/4885 |
| US-20150306107-A1 | SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia | SAAL1, HMOX1, HIF1AN | HTR7 3988/4885HTR6 1856/4885TSHR 4579/4885 |
| US-20130202549-A1 | USE OF DPAS AND CO-POLYMERS FOR HYPERLIPIDEMIA AND ATHEROSCLEROSIS ALONG WITH REDUCING FEEDING RATE AND ADIPOSE TISSUE WEIGHT OF OBESITY ANIMAL | LIPC, LPL, PNLIP | HTR7 169/4885HTR6 314/4885TSHR 3296/4885 |
| US-20080064705-A1 | Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation | TNNT2, NOS2, NOS1 | HTR7 357/4885HTR6 150/4885TSHR 1724/4885 |
| US-20170312286-A1 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | GYS2, PYGL, GYS1 | HTR7 4054/4885HTR6 3295/4885TSHR 3964/4885 |
| US-20110201618-A1 | KMUPS INHIBITING PROLIFERATION AND OBLITERATION OF PULMONARY ARTERY | MKI67, PTGIS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | HTR7 3669/4885HTR6 3143/4885TSHR 3639/4885 |
| US-20050209242-A1 | Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase | PDE3A, PDE5A, PDE3B | HTR7 120/4885HTR6 510/4885TSHR 2099/4885 |
| US-20150359798-A1 | PIPERAZINYL DERIVATIVE REDUCES HIGH-FAT DIET-INDUCED ACCUMULATION OF FAT IN THE LIVERS, THERAPEUTICALLY | FABP1, LIPC, PLIN5 | HTR7 3093/4885HTR6 2850/4885TSHR 4732/4885 |
| US-20150359901-A1 | PIPERAZINYL DERIVATIVE REDUCES HIGH-FAT DIET-INDUCED ACCUMULATION OF FAT IN THE LIVERS, THERAPEUTICALLY | FABP1, LIPC, PLIN5 | HTR7 3093/4885HTR6 2850/4885TSHR 4732/4885 |
| US-20190008870-A1 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | GYS2, PYGL, GYS1 | HTR7 4054/4885HTR6 3295/4885TSHR 3964/4885 |
| US-20150174157-A1 | INHALED NO DONOR PIPERAZINYL DERIVATIVE PREVENTING ALLERGIC PULMONARY VASCULAR AND BRONCHIAL INFLAMMATION BY REDUCING VEGF AND RESTORING eNOS IN HYPOXIC PULMONARY ARTERY | NOS2, NOS3, NOS1 | HTR7 3923/4885HTR6 4695/4885TSHR 4046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.